Abstract
A new disease caused by SARS-CoV-2, which began in China, in December 2019, has spread dramatically around the world. This was the reason that on March 11, 2020, the World Health Organization declared it a pandemic. Despite the fact that many articles about this disease have appeared since the beginning of the pandemic, there are still few reports concerning the manifestations of this disease among patients with congenital heart disease (CHD). Published large studies are either completely or mainly devoted to adults with CHD. Reports about children with CHD, including corrected ones, are limited and are presented with a description of several cases. Children count from 2% to 14% of all COVID-19 cases in the world. In general, they are less at risk of serious complications and mortality from this disease compared to adults. However, the presence of concomitant diseases, including CHD, increases the risk of complications and death. This paper presents a case of successful treatment of the patient with complex CHD who developed COVID-19 in the early postoperative period.
References
- Esmaeeli H., Ghaderian M., Zanjani K.S., Ghalibafan S.F., Mahdizadeh M., Aelami M.H. COVID-19 in children with congenital heart diseases: a multicenter case series from Iran. Case Rep. Pediatr. 2021: 6690695. DOI: 10.1155/2021/6690695
- Zareef R., Salameh E., Hammoud R., Tannouri T., Bitar F., Arabi M. COVID-19 in congenital heart disease patients: what did we learn?! Front. Cardiovasc. Med. 2023; 10: 1235165. DOI: 10.3389/fcvm.2023.1235165
- Zareef R.O., Younis N.K., Bitar F., Eid A.H., Arabi M. COVID-19 in pediatric patients: a focus on CHD patients. Front. Cardiovasc. Med. 2020; 7: 612460. DOI: 10.3389/fcvm.2020.612460
- Sachdeva S., Ramakrishnan S., Choubey M., Koneti N., Mani K., Bakhru S. et al. Outcome of COVID-19-positive children with heart disease and grown-ups with congenital heart disease: a multicentric study from India. Ann. Pediatr. Cardiol. 2021; 14 (3): 269–277. DOI: 10.4103/apc.apc_134_21
- Tan W., Aboulhosn J. The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease. Int. J. Cardiol. 2020; 309: 70–77. DOI: 10.1016/j.ijcard.2020.03.063
- COVID-19 (corona virus): Vulnerable groups with congenital heart disease. https://www.bcca-uk.org/pages/news_box.asp?NewsID=19495710.2020
- Haji Esmaeil Memar E., Pourakbari B., Gorgi M., Ekbatani M.S., Navaeian A., Khodabandeh M. et al. COVID-19 and congenital heart disease: a case series of nine children. World J. Pediatr. 2021; 17 (1): 71–78. DOI:10.1007/s12519-020-00397-7
- Sabatino J., Ferrero P., Chessa M., Bianco F., Ciliberti P., Secinaro A. et al. COVID-19 and congenital heart disease: results from a nationwide survey. J. Clin. Med. 2020; 9: 1774–1782.
- Sanna G., Serrau G., Bassareo P.P., Neroni P., Fanos V., Marcialis M.A. Children’s heart and COVID-19: up-to-date evidence in the form of a systematic review. Eur. J. Pediatr. 2020; 179 (7): 1079–1087. DOI:10.1007/s00431-020-03699-0
- Alsaied T., Aboulhosn J.A., Cotts T.B., Daniels C.J., Etheridge S.P., Feltes T.F. et al. Coronavirus disease 2019 (COVID-19) pandemic implications in pediatric and adult congenital heart disease. J. Am. Heart Assoc. 2020; 9 (12): e017224. DOI: 10.1161/JAHA.120.017224
- Schwerzmann M., Ruperti-Repilado F.J., Baumgartner H., Bouma B., Bouchardy J., Budts W. et al. Clinical outcome of COVID-19 in patients with adult congenital heart disease. Heart. 2021; 107 (15): 1226–1232. DOI:10.1136/heartjnl-2020-318467
About the authors
- Alana O. Tsokova, Junior Researcher, Pediatric Cardiologist; ORCID
- Viktor B. Samsonov, Dr. Med. Sci., Leading Researcher; ORCID
- Lale Ch. Yanybaeva, Cand. Med. Sci., Cardiologist; ORCID
- Yuliya D. Pirushkina, Resident Physician; ORCID
- Susanna A. Avakova, Cand. Med. Sci., Head of Scientific Advisory Department; ORCID
